Exploring the relationship between Insulin resistance and interferon resistance: options to overcome Hepatitis C Virus (HCV) non-response to pegylated interferon.

Trial Profile

Exploring the relationship between Insulin resistance and interferon resistance: options to overcome Hepatitis C Virus (HCV) non-response to pegylated interferon.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2012

At a glance

  • Drugs Pioglitazone (Primary) ; Peginterferon; Ribavirin
  • Indications Hepatitis C; Insulin resistance
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 23 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top